NHWK - NightHawk receives proceeds of $3.25M in sale of non-core IP January, 30 2024 08:14 AM NightHawk Biosciences Inc. 2024-01-30 08:14:38 ET More on NightHawk Biosciences NightHawk divesting Elusys assets to focus on CDMO contracts Seeking Alpha’s Quant Rating on NightHawk Biosciences Historical earnings data for NightHawk Biosciences Financial information for NightHawk Biosciences For further details see: NightHawk receives proceeds of $3.25M in sale of non-core IP